The survival life expectancy of patients after surgery for congenital heart disease reaches that of a normal person. If the surgery is performed successfully and corrected, the survival time is exactly the same as that of a normal person and there is no shortening of life expectancy due to the surgery. In addition, after the surgery, long-term cardiotonic and diuretic medications are required, through which the patient’s heart function can be restored. The choice of drugs include digoxin, spironolactone, cidilan, and coenzyme Q10, all of which can restore the patient’s heart function in order to maximize the patient’s recovery.